Affiliation:
1. Genetic Counseling Program MGH Institute of Health Professions Boston Massachusetts USA
2. Division of Cancer Genetics & Prevention Dana‐Farber Cancer Institute Boston Massachusetts USA
3. Cardiology Division, Cardiovascular Genetics Program Massachusetts General Hospital Boston Massachusetts USA
4. Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts USA
5. Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
6. Center for Fetal Medicine and Reproductive Genetics Brigham and Women's Hospital Boston Massachusetts USA
Abstract
AbstractPreimplantation genetic testing for monogenic disorders (PGT‐M) is a reproductive technology used in conjunction with in‐vitro fertilization (IVF) to reduce the risk of passing on a known genetic condition from parent to child. There is limited research describing the experience and emotional impact of PGT‐M among individuals with inherited aortic or vascular disease (IAVD). Our qualitative study aims to explore the factors that influence reproductive decision‐making and the uptake of PGT‐M within this population. Individuals diagnosed with IAVD who have considered PGT‐M, and/or their reproductive partner, were recruited using internal clinical databases and advocacy organizations. Virtual semi‐structured interviews were conducted using an interview guide that included questions related to participants' lived experience of their condition, risk perception, reproductive history, familiarity with PGT‐M/IVF, and financial/psychosocial considerations. A total of 17 interviews were completed (13 affected individuals, 4 unaffected partners) and analyzed using thematic analysis. Emergent themes included: (1) the lived experience and perceived severity of disease; (2) need for comprehensive, balanced, and timely information; (3) and impact of personal values and circumstances. When discussing the impact of lived experience on reproductive decision‐making, participants identified the physical and emotional impact of disease and variability of disease as factors influencing the uptake of PGT‐M. Many described PGT‐M as the only reproductive option presented to them by providers. Even so, participants expressed gaps in their understanding of PGT‐M, particularly regarding cost/insurance coverage and the experience of IVF. Finally, participants recognized that the decision to pursue PGT‐M primarily requires introspection and evaluation of one's values, but that cost remains a significant consideration. The findings from our study highlight the complexity of reproductive decision‐making for individuals with IAVD and provide insight into their psychological and informational needs when engaging in this process. Providers can use these findings to tailor their discussions about reproductive decision‐making with this patient cohort.
Funder
MGH Institute of Health Professions
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of prenatal genomics on clinical genetics practice;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-12
2. Preimplantation Genetic Testing for Inherited Heart Diseases;Current Cardiovascular Risk Reports;2023-09-06